MedTrace Logo

Pupil Dilation for Treatment of IFIS

NCT03760185 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2022-04-20

Study results available
· View outcomes & findings →

Summary

A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.

Conditions

  • Intraoperative Floppy Iris Syndrome

Interventions

DRUG

Brimonidine Tartrate

All subjects will apply brimonidine tartrate to one eye (right eye) only for the duration of study participation.

Sponsors & Collaborators

  • Denver Health and Hospital Authority

    lead OTHER

Principal Investigators

  • Cristos Ifantides, MD · Denver Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-04
Primary Completion
2020-09-25
Completion
2020-09-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03760185 on ClinicalTrials.gov